Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002974:Clemastine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000008:administration & dosage*; D011759:Pyrrolidines / Q000008:administration & dosage*; D011897:Random Allocation; D014311:Triprolidine / Q000008:administration & dosage* / Q000031:analogs & derivatives; D014581:Urticaria / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D011725:Pyridines; D011759:Pyrrolidines; D014311:Triprolidine; D002974:Clemastine; C043648:acrivastine